Parallel to the induction of oxidative capacity and the support of mitochondrial fusion to improve muscle atrophy and wasting, mTOR signaling inhibition has been described as a promising therapeutic strategy for chronic degenerative conditions exhibiting mTOR complex 1 (mTORC1) hyperactivation, such as muscular dystrophy [54]. This evidence concerns the gene MTOR and muscular dystrophy.